• Hepatitis B Virus (HBV) Antibody Panel for Acute and Chronic Infection
  • Peripheral Myelin Protein 22 (PMP22) Gene Mutation Analysis
  • Anti-Neutrophil Cytoplasmic Antibody (ANCA), IgG
  • Mitochondrial Fission Factor (MFF) Gene Mutation Analysis
  • Culture, Feces, Routine, with Campylobacter and Shiga Toxin Antigens, by EIA
  • Neuron-Specific Enolase (NSE), Serum
  • Gliadin (Deamidated) Antibody, IgG
  • Zinc, 24 Hour, Urine
  • JC Polyomavirus, Molecular
  • Treponema pallidum Antigen, Direct Fluorescent Antibody (DFA)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Overview
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...